The Benztropine Mesylate Tablets, cataloged under National Stock Number 6505-01-358-0131, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Goldline Laboratories, Inc. Dba Goldline Laboratories. Government technical data includes 6 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 2 commercial cross-references from 1 manufacturer, enabling identification through both NSN and commercial part number lookups. 5 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-358-0131 |
| Primary Part Number | NDC00182-1299-01 |
| Item Name | Benztropine Mesylate Tablets |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Goldline Laboratories, Inc. Dba Goldline Laboratories |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 100.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Features Provided | SCORED |
| Active Medicament Medicinal Strength | 0.500 MILLIGRAMS BENZTROPINE MESYLATE ACTIVE INGREDIENT |
| Primary Container Type | BOTTLE |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| 10890 | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
| NDC00182-1299-01 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
NSN 6505-01-358-0131 is a Benztropine Mesylate Tablets, manufactured by Goldline Laboratories, Inc. Dba Goldline Laboratories, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-358-0131 has 2 cross-referenced part numbers: 10890 (Goldline Laboratories, Inc. Dba Goldline Laboratories), NDC00182-1299-01 (Goldline Laboratories, Inc. Dba Goldline Laboratories).
There are 5 known substitutes for 6505-01-358-0131: 3110-00-100-3101, 4320-01-045-3939, 5998-01-068-5213 and 2 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00182-1299-01: Administration: ORAL; Primary Container Content Quantity: 100.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Features Provided: SCORED. 6 total characteristics are documented in the Federal Logistics Information System.